Federal judge in Texas suspends FDA approval of abortion pill The ruling from U.S. District Judge Matthew Kacsmaryk in Amarillo could potentially upend access to medication abortion nationwide.

Updated March 15, 2023 at 7:39 PM ET. Was the FDA wrong to approve a drug that's used in nearly all medication abortions in the U.S. — and should the drug, mifepristone, be taken off the market?

A case before a federal judge in Texas could have dramatic effects on abortion access nationwide as anti-abortion groups target the decades-long government approval of a key abortion drug.. A ...

AMARILLO, Texas — Federal judges in Texas have delivered time and again for abortion opponents. They upheld a state law that allows for $10,000 bounties to be placed on anyone who helps a woman ...

April 8(Reuters) - U.S. District Judge Matthew Kacsmaryk in Amarillo, Texas on Friday suspended approval of the abortion pill mifepristone, ... If the FDA wins a stay blocking the injunction, ...

Read full article: 5 people are in custody following a police raid at an after-hours club U.S. District Judge Matthew Kacsmaryk of Amarillo, Texas. (U.S. District Court, Northern District Of Texas ...

Lindsay London holds a protest sign in front of the federal court building in Amarillo, Texas, as a judge heard arguments Wednesday from a Christian group seeking to overturn the FDA’s more than ...

Jurisprudence Actually, One Texas Judge Is Not the Final Decision-Maker on Medication Abortion One district judge’s ruling does not have to affect the entire country.

The ruling from U.S. District Judge Matthew Kacsmaryk in Amarillo could potentially upend access to medication abortion nationwide. Skip to main content. Open Main Menu Navigation.

A federal judge in Texas spent four hours today hearing arguments in a case that could decide the future of access to the drug mifepristone, which is used in most medication abortions in the U.S ...

But the group incorporated an Amarillo outpost in August 2022, records from the Texas Secretary of State’s office show, three months before filing the lawsuit.

If the case succeeds, it could have sweeping repercussions — for abortion providers and patients across the nation, as well as for the FDA's drug-approval process. Search Query Show Search News ...